Zealand and Roche Obesity Drug Shows Up to 9.2% Weight Loss
Zealand Pharma's petrelintide helped diabetes patients lose up to 9.2% body weight in a 220-patient mid-stage trial announced October 7.
Simple explainers on world affairs, science, health and more.
All news under one minute
Zealand Pharma's petrelintide helped diabetes patients lose up to 9.2% body weight in a 220-patient mid-stage trial announced October 7.
Gold prices declined in Chennai on October 6: 24K down Rs 160 to Rs 1,49,020 per 10g; sovereign at Rs 1,09,280.
RBI data shows NBFC retail loans grew 22% in August 2026, with gold loans surging 69% to Rs 3.65 lakh crore.
Foxconn's Q3 revenue jumped 47% to $95.39 billion on AI server demand, beating estimates; September crossed T$1 trillion.
Apple partners with LG for smart doorbell, thermostat, lock and cameras; Apple's own hub launches October 13.
Apple's first foldable iPhone Duo starts at $1,999, goes on sale October 23 with 7.6-inch display and titanium build.
Arrive AI launches AP3 Plus with NVIDIA edge computing and on-board vision for autonomous drone and robot deliveries.
CPA Canada: organizational AI use jumped from 5% to 43% since 2023, but governance and training lag behind.
Claude arrives in Google Workspace: a sidebar that reads files and edits Docs, Sheets and Slides in place.
OpenAI's Decisions API enters public beta, promising decisions up to 10x faster than GPT-6 Luna.